Christopher M. Pease, PA

Christopher Pease practices at Christopher E. Beney, MD in Lockport, New York.

Christopher Pease's NPI, 1427083245, was assigned on July 11, 2006. Christopher Pease holds New York license 010083-1.

Christopher Pease's primary practice is Christopher E. Beney, MD, at 77 Elizabeth Dr, Lockport, NY 14094 in Niagara County. The practice phone is (716) 433-2674.

Christopher Pease's primary practice is Christopher E. Beney, MD in Lockport, New York. Christopher Pease is also affiliated with Mount St. Mary's Hospital. The medical group on file is Dr Christopher Beney. Dmand AI also links Christopher Pease to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Pease practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Christopher Pease's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Christopher Pease is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Christopher Pease is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, anxiety, arthritis, asthma, bursitis, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Christopher Pease treats.

CMS data shows 340 Medicare services from Christopher Pease across 8 procedure codes in 2024, for 111 Medicare patients. Medicare paid $16,937 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Christopher Pease in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Pease's median patient age at 53, with 34% women.

In 2024, Christopher Pease wrote 5,516 Medicare Part D claims for 512 patients. 86% of them were for generic drugs. CMS names the drug for 4,920 of them, across 109 drugs with 11 or more claims each, at $648,837 in total drug cost.

Christopher Pease accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Christopher Pease from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $18.

Christopher Pease is a member of AAPA.